Awarded contract
Published
Oncotype DX Breast Cancer Testing
8 suppliers have saved this notice.
Looks like a fit? Save this tender and qualify it in Stotles
Description
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient. Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Qualify tenders faster with AI summaries - see key details in the Stotles app
Never miss a tender again
Get alerts, AI summaries and tools to qualify faster
Explore similar pre-tenders, open or awarded contracts
Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.
Northern Health and Social Care Trust
94,346,764.84 GBP
Published 15 hours ago
Birmingham and Solihull Mental Health NHS Foundation Trust
647,569 GBP
Published 3 days ago
Awarded
Pathology Services with BSPS
Surrey and Borders Partnership NHS Foundation Trust
–
Published 7 days ago
Integrated Laboratory Solutions LLP
90,000 GBP
Published 8 days ago
Integrated Laboratory Solutions LLP
60,000 GBP
Published 8 days ago
Integrated Laboratory Solutions LLP
90,000 GBP
Published 8 days ago
Integrated Laboratory Solutions LLP
6,000 GBP
Published 8 days ago
Gloucestershire Hospitals NHS Foundation Trust
123,000 GBP
Published 9 days ago
Integrated Laboratory Solutions LLP
24,000 GBP
Published 15 days ago
Explore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
CPV Codes
Sign up to the Stotles Tender Tracker for free
Find even more contracts with advanced search capability and AI powered relevance scoring.